14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular...

92
BLADDER TUMORS BLADDER TUMORS z Benign Transitional Cell Papilloma 2-3% Inverted Papilloma Rare z Malignant Transitional (Urothelial) Carcinoma 90% Carcinoma In-Situ (By Itself) 5-10% S C ll C i 3 7% Squamous Cell Carcinoma 3-7% Adenocarcinoma 1% Small Cell Carcinoma Rare Small Cell Carcinoma Rare

Transcript of 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular...

Page 1: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

BLADDER TUMORSBLADDER TUMORS

Benign– Transitional Cell Papilloma 2-3%– Inverted Papilloma Rare

Malignant– Transitional (Urothelial) Carcinoma90%– Carcinoma In-Situ (By Itself) 5-10%

S C ll C i 3 7%– Squamous Cell Carcinoma 3-7%– Adenocarcinoma 1%

Small Cell Carcinoma Rare– Small Cell Carcinoma Rare

Page 2: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

INCIDENCE & PREVALENCEINCIDENCE & PREVALENCE

• 2% of all malignancies• Male predominanceMale predominance• Patients usually more than 60 years old

• Recently, there has been an increasing incidence among women and younger persons

Page 3: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

UROTHELIAL CARCINOMASUROTHELIAL CARCINOMAS

Genetic MutationsChromosomal Deletions– 9q, 11p, 13q and/or 17p, (p53 locus)– Occurrence in 30 to 60% of tumors

Increased Oncogene Expression– ras, c-myc, and/or EGF, y ,– Occurrence is less common and is less

well-defined

Page 4: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

ETIOLOGIC FACTORSETIOLOGIC FACTORSETIOLOGIC FACTORSETIOLOGIC FACTORS

Ch i titi• Chronic cystitis• Diverticula

Chronic irritation (e g stone disease)• Chronic irritation (e.g., stone disease)• Long-standing obstruction with retention

Cigarette smoking• Cigarette smoking• Schistosomiasis• Industrial Exposure to Carcinogens• Industrial Exposure to Carcinogens

NaphthalaminesBenzidineBenzidineAmino diphenylamines

Page 5: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

POOR PROGNOSTIC FACTORSPOOR PROGNOSTIC FACTORS

High Tumor Grade Advanced Tumor StageSquamous or Small Cell CarcinomaLoss of Blood Group AntigensHCG ExpressionI d E iIncreased c-myc Expressionp53 overexpressionM lti l Ch l M t tiMultiple Chromosomal Mutations

Page 6: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

MULTIFOCALITYMULTIFOCALITYDevelopment of multifocal tumors, either synchronous or metachronous, is commonDifficult to manage even when non-invasiveDifficult to manage, even when non-invasiveField effect theory-carcinogens in urine cause independent, genetically dissimilar tumorsMonoclonal theory-a single transformed cell proliferates and spreads throughout the urotheliumStudies support both theories. Both mechanisms can ppbe operative in a single patient

Page 7: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

HISTOLOGIC GRADINGHISTOLOGIC GRADINGPapillary Carcinoma (PTCC +/- Invasion) – Grade I Shows Uniform Tumor Cells

Grade II Shows Focal Pleomorphism and Rare– Grade II Shows Focal Pleomorphism and Rare mitoses

– Grade III Shows Moderate Pleomorphism and Occasional MitosesOccasional Mitoses

– Grade IV is Focally Unrecognizable as Urothelial, and May Show Spindle Cell FeaturesLow Grade (I II) and High Grade (III IV)– Low Grade (I,II) and High Grade (III, IV)

Flat Carcinoma (CIS and Invasive TCC)– Usually high grade

Page 8: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 9: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 10: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 11: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 12: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 13: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 14: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 15: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 16: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

UROTHELIAL CARCINOMAUROTHELIAL CARCINOMA

The status of the mucosa away from the tumor is important. Mucosal changes p g(e.g., CIS) increase the risk of recurrence and invasion.

Random bladder biopsiesExtensive sectioning and “mapping” of

cystectomy specimens

Page 17: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

UROTHELIAL CARCINOMAUROTHELIAL CARCINOMA

Not all CIS is high grade, and can be overlooked. Therefore, underdiagnosis , gis quite widespread.

Page 18: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 19: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 20: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 21: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

STAGING (TNM)STAGING (TNM)Depth of Local Invasion pT

CIS Tis

Non-invasive Papillary Ta

Lamina Propria T1

Superficial 1/2 Muscularis T2aSuperficial 1/2 Muscularis T2a

Deep 1/2 Muscularis T2b

Perivesical Fat T3

Prostatic stroma, Vagina, Uterus

T4a

Pelvic and/or Abdominal T4bWall

No Evidence of Primary Tumor

T0

Page 22: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

MODE OF INVASIONMODE OF INVASION

Broad FrontTentacularTentacularLymphaticsBl d V lBlood VesselsCombination

Page 23: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

INVASIONINVASION

The majority of invasive carcinomas present initially as invasive carcinomas. p yNon-invasive carcinomas can become invasiveinvasive. Both tend to be multicentric, and to recurrecur.

Page 24: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 25: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 26: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

THERAPYTHERAPY

BCGMitomycin-CMitomycin CThiotepaCi Pl tiCis-PlatinumCyclophosphamide, etc.SurgeryRadiationRadiation

Page 27: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SQUAMOUS CARCINOMASQUAMOUS CARCINOMA

Page 28: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SQUAMOUS CARCINOMASQUAMOUS CARCINOMA

Associated with:SchistosomiasisStonesChronic irritation

About 90% bladder cancers in the Mid-East and Egypt are squamous.Tend to be sessile ulcerated and invasive atTend to be sessile, ulcerated, and invasive at presentation. Except for verrucous variant they are poorlyExcept for verrucous variant, they are poorly differentiated.

Page 29: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 30: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 31: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 32: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

ADENOCARCINOMAADENOCARCINOMA

Page 33: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

ADENOCARCINOMAADENOCARCINOMAPrimary

- Urachal (dome and anterior wall)A i t d ith t h- Associated with exstrophy

- Associated with cystitis glandularis, colonic metaplasia, or villous adenoma p ,(usually in trigone)Secondary

Di t t i f l h (- Direct extension from elsewhere (e.g., prostate or rectum)Metastasisetastas s

Page 34: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 35: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 36: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

UNCOMMON VARIANTSUNCOMMON VARIANTS

Undifferentiated small cell carcinoma– May produce a paraneoplastic syndromeMay produce a paraneoplastic syndrome

via hormone synthesis (e.g. ACTH)Anaplastic TypeAnaplastic TypeSpindle Cell Type

? metaplasia– ? metaplasia– ? true carcinosarcoma

Page 37: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SMALL CELL CARCINOMASMALL CELL CARCINOMA

Page 38: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

NONNON--EPITHELIAL TUMORSEPITHELIAL TUMORS

BenignLeiomyoma– Leiomyoma

Malignant– Leiomyosarcoma– RhabdomyosarcomaRhabdomyosarcoma

– “Sarcoma Botryoides”

Page 39: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

RHABDOMYOSARCOMARHABDOMYOSARCOMA

Page 40: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

RHABDOMYOSARCOMARHABDOMYOSARCOMA

Page 41: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

RHABDOMYOSARCOMARHABDOMYOSARCOMA

Page 42: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

RENAL PELVIC TUMORSRENAL PELVIC TUMORSRENAL PELVIC TUMORSRENAL PELVIC TUMORS

The pelvic tumors (10-15% of all renal tumors) arise froma) the lining epithelium and are either:

1. TRANSITIONAL (UROTHELIAL) (75%), usually papillary2. SQUAMOUS (25%), usually solid, ± calculus, infiltrate kidney (silent)(silent)3. ADENOCARCINOMA4. MIXED (e.g. squamous and transitional)

b) stromal (non-epithelial) tumors are rare lipoma, fibroma, hemangioma, lymphangioma, etc. liposarcoma, fibrosarcoma, myosarcoma, etc.

Page 43: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 44: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 45: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 46: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 47: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 48: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 49: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 50: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

TESTICULAR TUMORSTESTICULAR TUMORS

Page 51: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

GERM CELL TUMORS OF THEGERM CELL TUMORS OF THEGERM CELL TUMORS OF THE GERM CELL TUMORS OF THE TESTISTESTIS

• 94% of testicular tumors- 38% single histologic type38% single histologic type- 62% more than one type

B i i t t b l li t• Begin as intratubular malignant germcells (ITGCN) (“CIS”) and progress to

hi t l i tone or more histologic types

Page 52: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 53: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

INCIDENCE & PREVALENCEINCIDENCE & PREVALENCEINCIDENCE & PREVALENCE INCIDENCE & PREVALENCE (U.S.)(U.S.)

6/100,000 (increasing incidence)11 - 13% of cancer deaths in 15 - 3411 13% of cancer deaths in 15 34 year age groupCommonest cause of death fromCommonest cause of death from malignancy in 20 - 34 year groupsR bl k i U S d Af iRare among blacks, in U.S. and Africa

Page 54: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

ETIOLOGY: UNKNOWNETIOLOGY: UNKNOWNGenetic - family history in 16%Chromosomal abnormalities-isochromosome

12p12pUndescended (Cryptorchid) testisInfection history of orchitis especially mumpsInfection - history of orchitis, especially mumpsTraumaAbnormal TestisAbnormal TestisEndocrine Abnormalities - intersex syndromesEnvironmental Factors – isolated cases noEnvironmental Factors isolated cases, no

consistent patterns

Page 55: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

TUMOR MARKERSTUMOR MARKERS

Done pre- and post-operatively

• BHCG - beta subunit of Human chronic gonadotroping p

• AFP - alphafetoprotein• HPL - human placental lactogenHPL human placental lactogen• SPI - pregnancy specific beta globulin• PLAP - placental alkaline phosphatase• PLAP placental alkaline phosphatase

Page 56: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

STAGING (TNM)STAGING (TNM)pTis: ITGCNpT1: Limited to testis &epididymis w/o vascular invasionvascular invasionpT2: Limited to testis & epididymis with vascular invasion, or invading tunica vaginalispT3: Invades spermatic cordpT4: Invades scrotum

N B d b d i f i l dpN: Based on number and size of involved regional nodespM: Distant metastasisp s a e as as s

Page 57: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SEMINOMASEMINOMA

About 50% of tumors in adults, mostly in pure formpNone seen in infantsAge 30’s 40’sAge 30 s - 40 sPLAP may be elevated Radiosensitive

Page 58: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

GROSSGROSS

Lobulated, soft pink-tan bulky mass. Rarely, hemorrhage and necrosis.y, g

Page 59: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 60: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

MICROMICRO

• Fairly uniform cells typically with clear cytoplasm and well-defined cell borders. Resemble primitive germ cells CytoplasmResemble primitive germ cells. Cytoplasm contains glycogen. Large vesicular nucleus with 1-2 nucleoli.

• Cells are arranged in lobules supported by a fibrovascular stroma in which almost invariably a lymphoid infiltration and granulomatous reaction are seengranulomatous reaction are seen.

Page 61: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 62: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 63: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 64: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 65: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SPERMATOCYTIC SEMINOMASPERMATOCYTIC SEMINOMA

Page 66: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

EMBRYONAL CARCINOMAEMBRYONAL CARCINOMA

• In pure form, constitutes 3.1%• Present in 47% of testicular tumors• Not seen in infants or children• AFP may be marginally elevated butAFP may be marginally elevated, but

able to be demonstrated in only 13% of cells. (Reported elevations due to ( poverlooked yolk sac tumor elements)

• HPL - more often elevated

Page 67: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

MICROMICRO

• Primitive epithelial cells form a carcinoma that is usually glandular, but y g ,may be papillary, tubular, or reticular.

• No cell bordersNo cell borders• Pleomorphism

“S th h” l i• “See-through” nuclei• Lymphovascular invasion common

Page 68: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 69: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 70: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 71: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 72: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

YOLK SAC TUMORYOLK SAC TUMOR

• Endodermal sinus tumor, infantile embryonal carcinoma, orchioblastomay ,

• 60% of testis tumors in children2 4% of adult tumors in pure form• 2.4% of adult tumors in pure form

• Present in 41% of all testis tumors• AFP almost always elevated in serum

and present in tumor cells by IHC (93%)

Page 73: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 74: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 75: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

CHORIOCARCINOMACHORIOCARCINOMA

Rare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal carcinoma or teratoma)with embryonal carcinoma or teratoma)Primary focus - small and often missed.Patients often present with symptoms ofPatients often present with symptoms of metastasis (hematogenous-to brain, lungs).Pure form - lethal within 6 weeksHCG - very high, AFP negativeGynecomastia, thyrotoxicosisy , y

Page 76: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

GROSSGROSS

Very small, soft, hemorrhagic mass

Page 77: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 78: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

MICROMICRO

• Recapitulates placental structures.• Prominent venous invasionProminent venous invasion.• Two cell types must be present:

S ti t h bl t- Syncytiotrophoblasts- Cytotrophoblasts

• Large choriocarcinomatous component probably worsens prognosis.p y p g

Page 79: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 80: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 81: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

TERATOMATERATOMA• Tumor showing disorderly arrangement of fetal and adult• Tumor showing disorderly arrangement of fetal and adult

tissues and structures representing 1 to 3 germ layers:- endoderm- mesoderm- ectoderm

• Subclassified as:- mature- immature

teratoma with malignant areas- teratoma with malignant areas1. adenocarcinoma2. squamous carcinoma3 S3. Sarcoma4. PNET

Page 82: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

TERATOMATERATOMA

About 40% of testicular germ cell tumors in infantsIn the adult (post-pubertal) testis, all are considered malignant regardless ofconsidered malignant regardless of histology (mature vs. immature)Rare epidermoid or dermoid cystsRare epidermoid or dermoid cysts

Page 83: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 84: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 85: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 86: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SEX CORD/ STROMALSEX CORD/ STROMALSEX CORD/ STROMAL SEX CORD/ STROMAL TUMORSTUMORS

Leydig cellSertoli cellSertoli cellGranulosa cellTh llTheca cellFibromaMixed/unclassified type

Page 87: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SEX CORD/ STROMALSEX CORD/ STROMALSEX CORD/ STROMAL SEX CORD/ STROMAL TUMORSTUMORS

All ages5-6% of testicular tumors5 6% of testicular tumorsNo racial predilectionR l li tRarely malignantHormone production-gynecomastia, precocious puberty

Page 88: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

LEYDIG CELL TUMORLEYDIG CELL TUMOR

Page 89: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 90: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal
Page 91: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal

SERTOLI CELL TUMORSERTOLI CELL TUMOR

Page 92: 14-Lecture 2 Presentation 2-3-10 - Columbia University · CHORIOCARCINOMA zRare (0.3% of testicular tumors) in pure form, but present in 16% of mixed GCTs (usually with embryonal